ArticleCancer immunology, immunotherapy : CII2022

ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC.

Shiqi Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.